ibbtec@unican.es

 

Skip Navigation LinksEspañol (España) > Investigación > Publicaciones > Detalle publicación

 

 

The Borg family of Cdc42 effector proteins Cdc42EP1-5The Borg family of Cdc42 effector proteins Cdc42EP1-5Farrugia AJ and Calvo F* 2016-12-01T23:00:00Z<p style="text-align:justify;">​<span class="ms-rteThemeFontFace-1 ms-rteFontSize-2" style="color:#121212;font-weight:bold;">Abstract</span></p><p style="color:#000000;margin-bottom:15px;padding:0px;border:0px;outline:0px;vertical-align:baseline;font-family:helvetica, arial, sans-serif;font-size:14px;font-stretch:inherit;line-height:inherit;word-wrap:break-word;text-align:justify;"><span class="ms-rteThemeFontFace-1 ms-rteFontSize-2">Despite being discovered more than 15 years ago, the Borg (binder of Rho GTPases) family of Cdc42 effector proteins (Cdc42EP1–5) remains largely uncharacterised and relatively little is known about their structure, regulation and role in development and disease. Recent studies are starting to unravel some of the key functional and mechanistic aspects of the Borg proteins, including their role in cytoskeletal remodelling and signalling. In addition, the participation of Borg proteins in important cellular processes such as cell shape, directed migration and differentiation is slowly emerging, directly linking Borgs with important physiological and pathological processes such as angiogenesis, neurotransmission and cancer-associated desmoplasia. Here, we review some of these findings and discuss future prospects.</span><br></p><p><a href="http://www.biochemsoctrans.org/content/44/6/1709">​Biochemical Society Transactions. Dec 02,44 (6) 1709-1716. </a><br></p>183
IBBTEC

Instituto de Biomedicina y Biotecnología de Cantabria.
PCTCAN - Cl. Albert Einstein, 22
39011 Santander

Inicio de sesión